2-TOIFA QANDLI DIABET BILAN OG‘RIGAN BEMORLARDA IKKI YO‘LLI TRANZIT BILAN SLEEVE GASTREKTOMIYA OPERATSIYASINING GLYUKEMIK NAZORATGA TA’SIRI
##article.subject##:
2-toifa qandli diabet, sleeve gastrektomiya, ikki yo‘lli tranzit, glyukemik nazorat, metabolik jarrohlik, HbA1c##article.abstract##
Dolzarblik. Semizlik bilan bog‘liq 2-toifa qandli diabet (2TQD) butun dunyoda jiddiy tibbiy-ijtimoiy muammo hisoblanadi. An’anaviy konservativ davolash usullari ko‘plab hollarda barqaror glyukemik nazoratni ta’minlay olmaydi. Shu bois metabolik jarrohlik, xususan ikki yo‘lli tranzit bilan sleeve gastrektomiya (SG-B), glyukemiyani yaxshilashda istiqbolli usul sifatida e’tirof etilmoqda.
Maqsad. 2-toifa qandli diabet bilan og‘rigan bemorlarda ikki yo‘lli tranzit bilan sleeve gastrektomiya operatsiyasining glyukemik nazoratga ta’sirini baholash.
Materiallar va usullari. Tadqiqotga 2TQD va semizlik tashxisi bilan SG-B operatsiyasi o‘tkazilgan bemorlar kiritildi. Glyukemik ko‘rsatkichlar (och qoringa glyukoza, HbA1c) operatsiyadan oldin hamda 3, 6 va 12 oyda baholandi. Natijalar statistik usullar yordamida tahlil qilindi.
Natijalar. Operatsiyadan keyingi davrda bemorlarda glyukemik ko‘rsatkichlarning sezilarli darajada yaxshilanishi kuzatildi. HbA1c va och qoringa glyukoza darajalarida statistik ahamiyatli pasayish qayd etildi. Ko‘plab bemorlarda qandni nazorat qilish uchun dori vositalariga bo‘lgan ehtiyoj kamaydi yoki butunlay bekor qilindi.
Xulosa. Ikki yo‘lli tranzit bilan sleeve gastrektomiya 2-toifa qandli diabet bilan og‘rigan bemorlarda glyukemik nazoratni yaxshilashda samarali metabolik jarrohlik usuli hisoblanadi. Ushbu operatsiya diabetni nazorat qilish va dori yuklamasini kamaytirishda muhim klinik ahamiyatga ega.
Библиографические ссылки
American Diabetes Association. Standards of medical care in diabetes — 2023. Diabetes Care. 2023;46(Suppl 1):S1–S291. doi:10.2337/dc23-Sint.
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2018. Obesity Surgery. 2020;30(10):1–12. doi:10.1007/s11695-020-04707-3.
Courcoulas AP, Yanovski SZ, Bonds D, et al. Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. JAMA Surgery. 2014;149(12):1323–1329. doi:10.1001/jamasurg.2014.2440.
Cummings DE, Overduin J. Gastrointestinal regulation of food intake. Journal of Clinical Investigation. 2007;117(1):13–23. doi:10.1172/JCI30227.
DePaula AL, Stival AR, DePaula CC, et al. Sleeve gastrectomy with ileal interposition (“two-segment transit”): metabolic effects and diabetes control. Surgery for Obesity and Related Diseases. 2015;11(5):1123–1130. doi:10.1016/j.soard.2015.01.012.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5-year follow-up. The Lancet. 2015;386(9997):964–973. doi:10.1016/S0140-6736(15)00075-6.
Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39(6):861–877. doi:10.2337/dc16-0236.
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes. New England Journal of Medicine. 2017;376:641–651. doi:10.1056/NEJMoa1600869.
World Health Organization. Global report on obesity: epidemiology, burden and prevention strategies. Geneva: WHO; 2022.
World Health Organization. Obesity and overweight. WHO Fact Sheet. Geneva: World Health Organization; 2023.
